[1]. Aleksandra Siekierska, et al. Gain-of-function FHF1 mutation causes early-onset epileptic encephalopathy with cerebellar atrophy. Neurology. 2016 Jun 7;86(23):2162-70.  [Content Brief]

[2]. Alessandro Esposito, et al. Biallelic DMXL2 mutations impair autophagy and cause Ohtahara syndrome with progressive course. Brain. 2019 Dec 1;142(12):3876-3891.  [Content Brief]

[3]. Ali Abdullah Alfaiz, et al. West syndrome caused by homozygous variant in the evolutionary conserved gene encoding the mitochondrial elongation factor GUF1. Eur J Hum Genet. 2016 Jul;24(7):1001-8.  [Content Brief]

[4]. Ali Torkamani, et al. De novo KCNB1 mutations in epileptic encephalopathy. Ann Neurol. 2014 Oct;76(4):529-540.  [Content Brief]

[5]. Amy McTague, et al. The genetic landscape of the epileptic encephalopathies of infancy and childhood. Lancet Neurol. 2016 Mar;15(3):304-16.  [Content Brief]

[6]. Anas M Alazami, et al. NECAP1 loss of function leads to a severe infantile epileptic encephalopathy. J Med Genet. 2014 Apr;51(4):224-8.  [Content Brief]

[7]. Andrew E Fry, et al. Missense variants in the N-terminal domain of the A isoform of FHF2/FGF13 cause an X-linked developmental and epileptic encephalopathy. Am J Hum Genet. 2021 Jan 7;108(1):176-185.  [Content Brief]

[8]. Anna Fassio, et al. De novo mutations of the ATP6V1A gene cause developmental encephalopathy with epilepsy. Brain. 2018 Jun 1;141(6):1703-1718.  [Content Brief]

[9]. Annalisa G Sega, et al. De novo pathogenic variants in neuronal differentiation factor 2 (NEUROD2) cause a form of early infantile epileptic encephalopathy. J Med Genet. 2019 Feb;56(2):113-122.  [Content Brief]

[10]. Annalisa Vetro, et al. ATP1A2- and ATP1A3-associated early profound epileptic encephalopathy and polymicrogyria. Brain. 2021 Jun 22;144(5):1435-1450.  [Content Brief]

[11]. Anne Schänzer, et al. Mutations in HID1 Cause Syndromic Infantile Encephalopathy and Hypopituitarism. Ann Neurol. 2021 Jul;90(1):143-158.  [Content Brief]

[12]. Atsushi Ishii, et al. A de novo missense mutation of GABRB2 causes early myoclonic encephalopathy. J Med Genet. 2017 Mar;54(3):202-211.  [Content Brief]

[13]. Candace T Myers, et al. De Novo Mutations in PPP3CA Cause Severe Neurodevelopmental Disease with Seizures. Am J Hum Genet. 2017 Oct 5;101(4):516-524.  [Content Brief]

[14]. Caroline Nava, et al. De novo mutations in HCN1 cause early infantile epileptic encephalopathy. Nat Genet. 2014 Jun;46(6):640-5.  [Content Brief]

[15]. Cas Simons, et al. Loss-of-function alanyl-tRNA synthetase mutations cause an autosomal-recessive early-onset epileptic encephalopathy with persistent myelination defect. Am J Hum Genet. 2015 Apr 2;96(4):675-81.  [Content Brief]

[16]. Chanshuai Han, et al. Epileptic Encephalopathy Caused by Mutations in the Guanine Nucleotide Exchange Factor DENND5A. Am J Hum Genet. 2016 Dec 1;99(6):1359-1367.  [Content Brief]

[17]. Chris Balak, et al. A novel FBXO28 frameshift mutation in a child with developmental delay, dysmorphic features, and intractable epilepsy: A second gene that may contribute to the 1q41-q42 deletion phenotype. Am J Med Genet A. 2018 Jul;176(7):1549-1558.  [Content Brief]

[18]. Clara D M van Karnebeek, et al. Bi-allelic GOT2 Mutations Cause a Treatable Malate-Aspartate Shuttle-Related Encephalopathy. Am J Hum Genet. 2019 Sep 5;105(3):534-548.  [Content Brief]

[19]. Dana Marafi, et al. Biallelic variants in SLC38A3 encoding a glutamine transporter cause epileptic encephalopathy. Brain. 2022 Apr 29;145(3):909-924.  [Content Brief]

[20]. Devon L Johnstone, et al. Compound heterozygous mutations in the gene PIGP are associated with early infantile epileptic encephalopathy. Hum Mol Genet. 2017 May 1;26(9):1706-1715.  [Content Brief]

[21]. Devon L Johnstone, et al. Early infantile epileptic encephalopathy due to biallelic pathogenic variants in PIGQ: Report of seven new subjects and review of the literature. J Inherit Metab Dis. 2020 Nov;43(6):1321-1332.  [Content Brief]

[22]. Dingding Shen, et al. De novo GABRG2 mutations associated with epileptic encephalopathies. Brain. 2017 Jan;140(1):49-67.  [Content Brief]

[23]. Dong Li, et al. GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers. Am J Hum Genet. 2016 Oct 6;99(4):802-816.  [Content Brief]

[24]. Elena Perenthaler, et al. Loss of UGP2 in brain leads to a severe epileptic encephalopathy, emphasizing that bi-allelic isoform-specific start-loss mutations of essential genes can cause genetic diseases. Acta Neuropathol. 2020 Mar;139(3):415-442.  [Content Brief]

[25]. Elizabeth E Palmer, et al. Neuronal deficiency of ARV1 causes an autosomal recessive epileptic encephalopathy. Hum Mol Genet. 2016 Jul 15;25(14):3042-3054.  [Content Brief]

[26]. Epi4K Consortium, et al. De Novo Mutations in SLC1A2 and CACNA1A Are Important Causes of Epileptic Encephalopathies. Am J Hum Genet. 2016 Aug 4;99(2):287-98.  [Content Brief]

[27]. Estelle Colin, et al. Biallelic Variants in UBA5 Reveal that Disruption of the UFM1 Cascade Can Result in Early-Onset Encephalopathy. Am J Hum Genet. 2016 Sep 1;99(3):695-703.  [Content Brief]

[28]. EuroEPINOMICS-RES Consortium, et al. De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. Am J Hum Genet. 2014 Oct 2;95(4):360-70.  [Content Brief]

[29]. Fadi F Hamdan, et al. High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies. Am J Hum Genet. 2017 Nov 2;101(5):664-685.  [Content Brief]

[30]. Florence Molinari, et al. Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy. Am J Hum Genet. 2005 Feb;76(2):334-9.  [Content Brief]

[31]. Gemma L Carvill, et al. GABRA1 and STXBP1: novel genetic causes of Dravet syndrome. Neurology. 2014 Apr 8;82(14):1245-53.  [Content Brief]

[32]. Gemma L Carvill, et al. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genet. 2013 Jul;45(7):825-30.  [Content Brief]

[33]. Ghada Abdel-Salam, et al. The supposed tumor suppressor gene WWOX is mutated in an early lethal microcephaly syndrome with epilepsy, growth retardation and retinal degeneration. Orphanet J Rare Dis. 2014 Jan 23;9:12.  [Content Brief]

[34]. Giulia Barcia, et al. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet. 2012 Nov;44(11):1255-9.  [Content Brief]

[35]. Gustavo A Patino, et al. A functional null mutation of SCN1B in a patient with Dravet syndrome. J Neurosci. 2009 Aug 26;29(34):10764-78.  [Content Brief]

[36]. Heather E Olson, et al. A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis. Am J Hum Genet. 2018 May 3;102(5):995-1007.  [Content Brief]

[37]. Hirofumi Kodera, et al. De novo mutations in SLC35A2 encoding a UDP-galactose transporter cause early-onset epileptic encephalopathy. Hum Mutat. 2013 Dec;34(12):1708-14.  [Content Brief]

[38]. Hiroki Mutoh, et al. Biallelic Variants in CNPY3, Encoding an Endoplasmic Reticulum Chaperone, Cause Early-Onset Epileptic Encephalopathy. Am J Hum Genet. 2018 Feb 1;102(2):321-329.  [Content Brief]

[39]. Hirotomo Saitsu, et al. De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy. Nat Genet. 2008 Jun;40(6):782-8.  [Content Brief]

[40]. Hirotomo Saitsu, et al. Dominant-negative mutations in alpha-II spectrin cause West syndrome with severe cerebral hypomyelination, spastic quadriplegia, and developmental delay. Am J Hum Genet. 2010 Jun 11;86(6):881-91.  [Content Brief]

[41]. Hisato Suzuki, et al. De novo NSF mutations cause early infantile epileptic encephalopathy. Ann Clin Transl Neurol. 2019 Nov;6(11):2334-2339.  [Content Brief]

[42]. Holger Hengel, et al. Loss-of-function mutations in UDP-Glucose 6-Dehydrogenase cause recessive developmental epileptic encephalopathy. Nat Commun. 2020 Jan 30;11(1):595.  [Content Brief]

[43]. Hyung-Lok Chung, et al. De Novo Variants in CDK19 Are Associated with a Syndrome Involving Intellectual Disability and Epileptic Encephalopathy. Am J Hum Genet. 2020 May 7;106(5):717-725.  [Content Brief]

[44]. Ilaria Guella, et al. De Novo Mutations in YWHAG Cause Early-Onset Epilepsy. Am J Hum Genet. 2017 Aug 3;101(2):300-310.  [Content Brief]

[45]. Isabelle Perrault, et al. Mutations in DOCK7 in individuals with epileptic encephalopathy and cortical blindness. Am J Hum Genet. 2014 Jun 5;94(6):891-7.  [Content Brief]

[46]. J Conroy, et al. NAPB - a novel SNARE-associated protein for early-onset epileptic encephalopathy. Clin Genet. 2016 Feb;89(2):E1-3.  [Content Brief]

[47]. J Nakajima, et al. De novo EEF1A2 mutations in patients with characteristic facial features, intellectual disability, autistic behaviors and epilepsy. Clin Genet. 2015 Apr;87(4):356-61.  [Content Brief]

[48]. Jeanne Hansen, et al. De novo mutations in SIK1 cause a spectrum of developmental epilepsies. Am J Hum Genet. 2015 Apr 2;96(4):682-90.  [Content Brief]

[49]. Jenna M Lentini, et al. DALRD3 encodes a protein mutated in epileptic encephalopathy that targets arginine tRNAs for 3-methylcytosine modification. Nat Commun. 2020 May 19;11(1):2510.  [Content Brief]

[50]. Johannes Koch, et al. CAD mutations and uridine-responsive epileptic encephalopathy. Brain. 2017 Feb;140(2):279-286.  [Content Brief]

[51]. Johannes R Lemke, et al. Delineating the GRIN1 phenotypic spectrum: A distinct genetic NMDA receptor encephalopathy. Neurology. 2016 Jun 7;86(23):2171-8.  [Content Brief]

[52]. Johannes R Lemke, et al. GRIN2B mutations in West syndrome and intellectual disability with focal epilepsy. Ann Neurol. 2014 Jan;75(1):147-54.  [Content Brief]

[53]. Jonas Straub, et al. Missense Variants in RHOBTB2 Cause a Developmental and Epileptic Encephalopathy in Humans, and Altered Levels Cause Neurological Defects in Drosophila. Am J Hum Genet. 2018 Jan 4;102(1):44-57.  [Content Brief]

[54]. Julien Thevenon, et al. Mutations in SLC13A5 cause autosomal-recessive epileptic encephalopathy with seizure onset in the first days of life. Am J Hum Genet. 2014 Jul 3;95(1):113-20.  [Content Brief]

[55]. Jun Shen, et al. Mutations in PNKP cause microcephaly, seizures and defects in DNA repair. Nat Genet. 2010 Mar;42(3):245-9.  [Content Brief]

[56]. Kameryn M Butler, et al. De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy. Brain. 2018 Aug 1;141(8):2392-2405.  [Content Brief]

[57]. Karin Dedek, et al. Neonatal convulsions and epileptic encephalopathy in an Italian family with a missense mutation in the fifth transmembrane region of KCNQ2. Epilepsy Res. 2003 Apr;54(1):21-7.  [Content Brief]

[58]. Katherine L Helbig, et al. De Novo Pathogenic Variants in CACNA1E Cause Developmental and Epileptic Encephalopathy with Contractures, Macrocephaly, and Dyskinesias. Am J Hum Genet. 2018 Nov 1;103(5):666-678.  [Content Brief]

[59]. Katia Hardies, et al. Loss of SYNJ1 dual phosphatase activity leads to early onset refractory seizures and progressive neurological decline. Brain. 2016 Sep;139(Pt 9):2420-30.  [Content Brief]

[60]. Kazusaku Kamiya, et al. A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline. J Neurosci. 2004 Mar 17;24(11):2690-8.  [Content Brief]

[61]. Kazushi Aoto, et al. ATP6V0A1 encoding the a1-subunit of the V0 domain of vacuolar H+-ATPases is essential for brain development in humans and mice. Nat Commun. 2021 Apr 8;12(1):2107.  [Content Brief]

[62]. Kazuyuki Nakamura, et al. De Novo mutations in GNAO1, encoding a Gαo subunit of heterotrimeric G proteins, cause epileptic encephalopathy. Am J Hum Genet. 2013 Sep 5;93(3):496-505.  [Content Brief]

[63]. Kirsten Harvey, et al. The GDP-GTP exchange factor collybistin: an essential determinant of neuronal gephyrin clustering. J Neurosci. 2004 Jun 23;24(25):5816-26.  [Content Brief]

[64]. Krishna R Veeramah, et al. De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP. Am J Hum Genet. 2012 Mar 9;90(3):502-10.  [Content Brief]

[65]. Leanne M Dibbens, et al. X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment. Nat Genet. 2008 Jun;40(6):776-81.  [Content Brief]

[66]. Lina Basel-Vanagaite, et al. Biallelic SZT2 mutations cause infantile encephalopathy with epilepsy and dysmorphic corpus callosum. Am J Hum Genet. 2013 Sep 5;93(3):524-9.  [Content Brief]

[67]. Linda S Weaving, et al. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am J Hum Genet. 2004 Dec;75(6):1079-93.  [Content Brief]

[68]. Luigi Vetri, et al. A de novo heterozygous mutation in KCNC2 gene implicated in severe developmental and epileptic encephalopathy. Eur J Med Genet. 2020 Apr;63(4):103848.  [Content Brief]

[69]. Lynne Rumping, et al. Identification of a Loss-of-Function Mutation in the Context of Glutaminase Deficiency and Neonatal Epileptic Encephalopathy. JAMA Neurol. 2019 Mar 1;76(3):342-350.  [Content Brief]

[70]. Manju A Kurian, et al. Phospholipase C beta 1 deficiency is associated with early-onset epileptic encephalopathy. Brain. 2010 Oct;133(10):2964-70.  [Content Brief]

[71]. Marina C Gonsales, et al. Recent developments in the genetics of childhood epileptic encephalopathies: impact in clinical practice. Arq Neuropsiquiatr. 2015 Nov;73(11):946-58.  [Content Brief]

[72]. Mathieu Milh, et al. Novel compound heterozygous mutations in TBC1D24 cause familial malignant migrating partial seizures of infancy. Hum Mutat. 2013 Jun;34(6):869-72.  [Content Brief]

[73]. Melissa H Broeks, et al. MDH1 deficiency is a metabolic disorder of the malate-aspartate shuttle associated with early onset severe encephalopathy. Hum Genet. 2019 Dec;138(11-12):1247-1257.  [Content Brief]

[74]. Mikko Muona, et al. Dysfunctional ADAM22 implicated in progressive encephalopathy with cortical atrophy and epilepsy. Neurol Genet. 2016 Jan 21;2(1):e46.  [Content Brief]

[75]. Min Ni, et al. A pathogenic UFSP2 variant in an autosomal recessive form of pediatric neurodevelopmental anomalies and epilepsy. Genet Med. 2021 May;23(5):900-908.  [Content Brief]

[76]. Mirna Assoum, et al. Autosomal-Recessive Mutations in AP3B2, Adaptor-Related Protein Complex 3 Beta 2 Subunit, Cause an Early-Onset Epileptic Encephalopathy with Optic Atrophy. Am J Hum Genet. 2016 Dec 1;99(6):1368-1376.  [Content Brief]

[77]. Mitsuko Nakashima, et al. De novo hotspot variants in CYFIP2 cause early-onset epileptic encephalopathy. Ann Neurol. 2018 Apr;83(4):794-806.  [Content Brief]

[78]. Nanako Hamada, et al. De novo PHACTR1 mutations in West syndrome and their pathophysiological effects. Brain. 2018 Nov 1;141(11):3098-3114.  [Content Brief]

[79]. Nicolas Chatron, et al. Bi-allelic GAD1 variants cause a neonatal onset syndromic developmental and epileptic encephalopathy. Brain. 2020 May 1;143(5):1447-1461.  [Content Brief]

[80]. Nicolas Chatron, et al. The epilepsy phenotypic spectrum associated with a recurrent CUX2 variant. Ann Neurol. 2018 May;83(5):926-934.  [Content Brief]

[81]. Nicolas Lebrun, et al. Early-onset encephalopathy with epilepsy associated with a novel splice site mutation in SMC1A. Am J Med Genet A. 2015 Dec;167A(12):3076-81.  [Content Brief]

[82]. Ortal Barel, et al. Deleterious variants in TRAK1 disrupt mitochondrial movement and cause fatal encephalopathy. Brain. 2017 Mar 1;140(3):568-581.  [Content Brief]

[83]. Petter Strømme, et al. Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy. Nat Genet. 2002 Apr;30(4):441-5.  [Content Brief]

[84]. R Shaheen, et al. Epileptic encephalopathy with continuous spike-and-wave during sleep maps to a homozygous truncating mutation in AMPA receptor component FRRS1L. Clin Genet. 2016 Sep;90(3):282-3.  [Content Brief]

[85]. Rolf Wibom, et al. AGC1 deficiency associated with global cerebral hypomyelination. N Engl J Med. 2009 Jul 30;361(5):489-95.  [Content Brief]

[86]. Rosemary Burgess, et al. The Genetic Landscape of Epilepsy of Infancy with Migrating Focal Seizures. Ann Neurol. 2019 Dec;86(6):821-831.  [Content Brief]

[87]. Samira Ait-El-Mkadem, et al. Mutations in MDH2, Encoding a Krebs Cycle Enzyme, Cause Early-Onset Severe Encephalopathy. Am J Hum Genet. 2017 Jan 5;100(1):151-159.  [Content Brief]

[88]. Scott Bell, et al. Mutations in ACTL6B Cause Neurodevelopmental Deficits and Epilepsy and Lead to Loss of Dendrites in Human Neurons. Am J Hum Genet. 2019 May 2;104(5):815-834.  [Content Brief]

[89]. Sharita Timal, et al. Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing. Hum Mol Genet. 2012 Oct 1;21(19):4151-61.  [Content Brief]

[90]. Shunsuke Ohtahara, et al. Epileptic encephalopathies in early infancy with suppression-burst. J Clin Neurophysiol. 2003 Nov-Dec;20(6):398-407.  [Content Brief]

[91]. Shunsuke Ohtahara, et al. Ohtahara syndrome: with special reference to its developmental aspects for differentiating from early myoclonic encephalopathy. Epilepsy Res. 2006 Aug;70 Suppl 1:S58-67.  [Content Brief]

[92]. Sietske H Kevelam, et al. Recessive ITPA mutations cause an early infantile encephalopathy. Ann Neurol. 2015 Oct;78(4):649-58.  [Content Brief]

[93]. Silke Redler, et al. Variants in CPLX1 in two families with autosomal-recessive severe infantile myoclonic epilepsy and ID. Eur J Hum Genet. 2017 Jun;25(7):889-893.  [Content Brief]

[94]. Simon Edvardson, et al. Heterozygous RNF13 Gain-of-Function Variants Are Associated with Congenital Microcephaly, Epileptic Encephalopathy, Blindness, and Failure to Thrive. Am J Hum Genet. 2019 Jan 3;104(1):179-185.  [Content Brief]

[95]. Simon Edvardson, et al. West syndrome caused by ST3Gal-III deficiency. Epilepsia. 2013 Feb;54(2):e24-7.  [Content Brief]

[96]. Steffen Syrbe, et al. De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy. Nat Genet. 2015 Apr;47(4):393-399.  [Content Brief]

[97]. Sushmitha Gururaj, et al. A De Novo Mutation in the Sodium-Activated Potassium Channel KCNT2 Alters Ion Selectivity and Causes Epileptic Encephalopathy. Cell Rep. 2017 Oct 24;21(4):926-933.  [Content Brief]

[98]. Tariq Zaman, et al. Mutations in SCN3A cause early infantile epileptic encephalopathy. Ann Neurol. 2018 Apr;83(4):703-717.  [Content Brief]

[99]. Thi Tuyet Mai Nguyen, et al. Mutations in PIGS, Encoding a GPI Transamidase, Cause a Neurological Syndrome Ranging from Fetal Akinesia to Epileptic Encephalopathy. Am J Hum Genet. 2018 Oct 4;103(4):602-611.  [Content Brief]

[100]. Tommy Stödberg, et al. Mutations in SLC12A5 in epilepsy of infancy with migrating focal seizures. Nat Commun. 2015 Sep 3;6:8038.  [Content Brief]

[101]. Toshiyuki Itai, et al. De novo variants in CELF2 that disrupt the nuclear localization signal cause developmental and epileptic encephalopathy. Hum Mutat. 2021 Jan;42(1):66-76.  [Content Brief]

[102]. Tsukasa Ohashi, et al. Infantile epileptic encephalopathy with a hyperkinetic movement disorder and hand stereotypies associated with a novel SCN1A mutation. Epileptic Disord. 2014 Jun;16(2):208-12.  [Content Brief]

[103]. Xiaomeng Yin, et al. The genotypic and phenotypic spectrum of PARS2-related infantile-onset encephalopathy. J Hum Genet. 2018 Sep;63(9):971-980.  [Content Brief]

[104]. Yasuko Yamatogi, et al. Early-infantile epileptic encephalopathy with suppression-bursts, Ohtahara syndrome; its overview referring to our 16 cases. Brain Dev. 2002 Jan;24(1):13-23.  [Content Brief]

[105]. Yoshiko Murakami, et al. Mutations in PIGB Cause an Inherited GPI Biosynthesis Defect with an Axonal Neuropathy and Metabolic Abnormality in Severe Cases. Am J Hum Genet. 2019 Aug 1;105(2):384-394.  [Content Brief]